HRMY or ONC: Which Is the Better Value Stock Right Now?

Core Insights - The article compares Harmony Biosciences Holdings, Inc. (HRMY) and BeiGene, Ltd. (ONC) to determine which stock is more attractive to value investors [1] Group 1: Zacks Rank and Earnings Outlook - HRMY has a Zacks Rank of 1 (Strong Buy), indicating a stronger improvement in its earnings outlook compared to ONC, which has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank strategy targets companies with positive earnings estimate revision trends, which is a key factor for value investors [2] Group 2: Valuation Metrics - HRMY has a forward P/E ratio of 12.33, significantly lower than ONC's forward P/E of 410.78, suggesting HRMY is more undervalued [5] - The PEG ratio for HRMY is 0.52, while ONC's PEG ratio is 9.21, indicating HRMY's expected EPS growth rate is more favorable [5] - HRMY's P/B ratio is 3.72, compared to ONC's P/B of 6.54, further supporting HRMY's valuation attractiveness [6] Group 3: Value Grades - HRMY has a Value grade of A, while ONC has a Value grade of D, highlighting HRMY's superior valuation metrics [6] - The combination of Zacks Rank and Style Scores indicates that HRMY is the better option for value investors at this time [6]